secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEWMARK GROUP, INC. (NMRK)
CIK:        0001690680
Form:       8-K
Filed at:   2021-10-19T23:59:59+00:00
Accession:  0001628280-21-020209
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Chairman Howard Lutnick discloses Non-Hodgkin's Lymphoma diagnosis, expects full recovery in 4 months
--------------------------------------------------------------------------------

- Howard Lutnick diagnosed with highly treatable Non-Hodgkin's Lymphoma; expects to be cancer-free in 4 months.
- Treatment includes six chemotherapy sessions from Oct 18, 2021 through end of Jan 2022.
- Lutnick plans to continue serving as Chairman during treatment period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690680/000162828021020209/0001628280-21-020209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690680/000162828021020209/nmrk-20211018.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-020209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer